Albireo Pharma appoints Dr Anne Klibanski and Stephanie Okey to its Board of Directors
– USA, MA – Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the election of Anne Klibanski, M.D…